证券代码：603041 证券简称： 美思德公告编号：2024-019 江苏美思德化学股份有限公司 关于提请股东大会授权董事会办理小额快速融资相关事宜 的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 江苏美思德化学股份有限公司（以下简称"公司"）于 2024 年 04 月 25 日 召开了第四届董事会第十四次会议，审议通过了《关于提请股东大会授权董事会 办理小额快速融资相关事宜的议案》，上述议案尚需提交 2023 年年度股东大会 审议。 为提高公司股权融资决策效率，根据《上市公司证券发行注册管理办法》（以 下简称"《注册管理办法》"）《上海证券交易所上市公司证券发行上市审核规 则》《上海证券交易所上市公司证券发行与承销业务实施细则》等相关规定，公 司董事会提请股东大会授权董事会决定向特定对象发行融资总额不超过人民币 3 亿元且不超过最近一年末净资产 20%的股票，授权期限为 2023 年年度股东大会 通过之日起至 2024 年年度股东大会召开之日止。本次授权事宜包括以下内容： 1、确认公司是否符合以简易程序向特定对象发行 ...

证券代码：603041 证券简称：美思德 公告编号：2024-005 江苏美思德化学股份有限公司 第四届监事会第十三次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、监事会会议召开情况 江苏美思德化学股份有限公司（以下简称"公司"）第四届监事会第十三次 会议（以下简称"本次监事会会议"）通知于 2024 年 04 月 15 日以电子邮件等 方式发出，通知了公司第四届监事会的全体监事和其他列席人员。公司本次监事 会会议于 2024 年 04 月 25 日（星期四）上午在南京经济技术开发区恒泰路 8 号 汇智科技园 A3 栋之公司 701 会议室以现场结合通讯投票表决的方式召开。公司 本次监事会会议应到监事 3 人，实到监事 3 人。 公司本次监事会会议由公司监事会主席宋琪女士召集和主持。公司董事会秘 书、财务总监和证券事务代表列席了本次监事会会议。公司本次监事会会议的召 集程序、召开程序以及参与表决的监事人数符合《中华人民共和国公司法》、《公 司章程》、《公司监事会议事规则》等的相关规定。 二、监事会会议审议情 ...

Financial Performance - The company's operating revenue for Q1 2024 was CNY 146,878,544.34, representing a year-on-year increase of 22.27%[5] - The net profit attributable to shareholders for the same period was CNY 30,888,899.23, reflecting a growth of 25.85% compared to the previous year[5] - The basic earnings per share (EPS) was CNY 0.17, which is an increase of 21.43% year-on-year[5] - Total operating revenue for Q1 2024 reached ¥146,878,544.34, a 22.3% increase from ¥120,127,795.35 in Q1 2023[17] - Net profit for Q1 2024 was ¥30,829,303.58, representing a 25.7% increase compared to ¥24,536,134.56 in Q1 2023[18] - Basic and diluted earnings per share for Q1 2024 were both ¥0.17, up from ¥0.14 in Q1 2023[19] - The company reported a comprehensive income total of ¥30,772,013.07 for Q1 2024, compared to ¥24,640,044.78 in Q1 2023[19] Cash Flow and Liquidity - The net cash flow from operating activities decreased by 37.02%, primarily due to increased cash payments for raw materials[8] - Cash inflow from operating activities in Q1 2024 was ¥136,868,459.31, compared to ¥105,246,612.60 in Q1 2023, marking a 30.1% increase[22] - Net cash flow from operating activities was 6,754,464.43, a decrease from 10,724,668.22 in the previous period[23] - Total cash outflow from operating activities amounted to 130,113,994.88, compared to 94,521,944.38 previously[23] - The ending balance of cash and cash equivalents was 135,436,904.25, down from 151,180,920.26[24] - Total cash and cash equivalents decreased by 80,147,233.05, compared to a decrease of 122,951,731.84 in the previous period[24] Assets and Liabilities - Total assets at the end of the reporting period were CNY 1,770,955,230.82, up 1.08% from the end of the previous year[6] - The company's current assets totaled RMB 1,002,008,432.63, up from RMB 974,867,273.98 at the end of 2023, indicating a growth of approximately 2.3%[14] - Cash and cash equivalents decreased to RMB 274,259,206.54 from RMB 365,668,877.24, reflecting a decline of about 25%[13] - The company's inventory increased significantly to RMB 127,133,470.15 from RMB 98,539,527.24, representing a growth of approximately 29%[14] - Short-term borrowings rose sharply to RMB 19,995,426.39 from RMB 5,450,199.90, indicating an increase of over 267%[14] - The company's accounts receivable increased to RMB 103,701,522.18 from RMB 97,616,446.27, showing a growth of approximately 6.9%[13] - Total liabilities decreased to ¥279,903,824.45 in Q1 2024 from ¥291,452,865.22 in Q1 2023[16] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 9,181[10] - The largest shareholder, Foshan Shunde Demai Chemical Group Co., Ltd., holds 40.88% of the shares, with 5,720,000 shares pledged[10] - The company has not reported any significant changes in shareholder structure or major strategic initiatives during the reporting period[12] Research and Development - Research and development expenses for Q1 2024 totaled ¥9,138,658.42, an increase of 52.5% from ¥5,986,975.06 in Q1 2023[17] Government Subsidies - The company received government subsidies amounting to CNY 283,522.84, which are closely related to its normal business operations[7] Accounting Standards - The company has not adopted new accounting standards or interpretations starting from 2024[25]

| 保荐机构名称： | 被保荐公司名称： | | --- | --- | | 中信建投证券股份有限公司 | 江苏美思德化学股份有限公司 | | 保荐代表人姓名：周子昊 | 联系方式：021-68828047 联系地址：上海市浦东南路 528 号上海 | | | 证券大厦北塔 2206 室 | | 保荐代表人姓名：王傲东 | 联系方式：021-68828047 528 号上海 | | | 联系地址：上海市浦东南路 | | | 证券大厦北塔 室 2206 | 经中国证券监督管理委员会（简称"中国证监会"）《关于核准江苏美思德化 学股份有限公司非公开发行股票的批复》（证监许可〔2021〕4029 号）文件批准， 江苏美思德化学股份有限公司（简称"公司"或"美思德"）本次非公开发行人民币 普通股（A 股）42,264,852 股，本次公司发行新股的发行价为 10.08 元/股，募集 资金总额为 426,029,708.16 元，扣除不含税发行费用 9,871,787.41 元后，实际募 集资金净额为 416,157,920.75 元。本次非公开发行股票于 2022 年 4 月 27 日在上 海证券交易所上市。中信建投 ...

中信建投证券股份有限公司（以下简称"保荐机构"）作为江苏美思德化学股 份有限公司（以下简称"美思德"或"公司"）非公开发行证券项目的保荐机构，根 据《证券发行上市保荐业务管理办法》（以下简称"《保荐办法》"）以及《上海证 券交易所上市公司自律监管指引第 11 号——持续督导》（以下简称"《持续督 导》"）等相关法规规定，担任美思德非公开发行项目持续督导的保荐机构，于 2024 年 4 月 16 日至 2024 年 4 月 18 日对公司进行了现场检查。现将本次现场检查 情况报告如下： 一、本次现场检查的基本情况 保荐机构于 2024 年 4 月 16 日至 2024 年 4 月 18 日对美思德进行了现场检查。 参加人员为王傲东、张宇熙。 中信建投证券股份有限公司关于江苏美思德化学股份有限公司 2023 年度持续督导现场检查报告 在现场检查过程中，保荐机构结合美思德的实际情况，查阅、收集了公司有 关文件资料，与公司管理人员进行了访谈，实施了包括审核、查证、询问等必要 程序，检查了公司治理和内部控制、信息披露、公司的独立性以及与控股股东及 其他关联方资金往来、募集资金使用、关联交易、对外担保、重大对外投资以及 ...

中信建投证券股份有限公司（以下简称"中信建投证券"、"本保荐机构"） 接受江苏美思德化学股份有限公司（以下简称"美思德"、"公司"）的委托，担 任作为美思德非公开发行股票的保荐机构，持续督导期限截至 2023 年 12 月 31 日。截至 2023 年 12 月 31 日，美思德非公开发行股票持续督导期限已经届满。 中信建投证券现根据《证券发行上市保荐业务管理办法》等相关规定，出具本持 续督导保荐总结报告书。 一、保荐机构及保荐代表人承诺 1、保荐总结报告书和证明文件及其相关资料的内容不存在虚假记载、误导 性陈述或重大遗漏，保荐机构及保荐代表人对其真实性、准确性、完整性承担法 律责任。 2、本机构及本人自愿接受中国证监会对保荐总结报告书相关事项进行的任 何质询和调查。 3、本机构及本人自愿接受中国证监会按照《证券发行上市保荐业务管理办 法》的有关规定采取的监管措施。 中信建投证券股份有限公司 关于江苏美思德化学股份有限公司 非公开发行股票持续督导保荐工作总结报告书 | 保荐机构名称 | 中信建投证券股份有限公司 | | --- | --- | | 注册地址 | 北京市朝阳区安立路 66 号 4 号楼 | | ...

证券代码：603041 证券简称：美思德 公告编号：2024-001 2024 年 01 月 24 日 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 江苏美思德化学股份有限公司（以下简称"公司"）监事会于近日收到公司 职工代表监事庄新玲女士的书面辞职报告。庄新玲女士因个人原因申请辞去公司 第四届监事会职工代表监事职务，辞去职工代表监事职务后，庄新玲女士在公司 及子公司不再担任任何职务。公司及监事会对庄新玲女士在任职期间所做的贡献 表示衷心感谢。 为保证公司监事会的正常运作，根据《中华人民共和国公司法》、《公司章 程》等有关规定，公司于 2024 年 01 月 22 日召开职工代表大会，经出席本次会 议的全体职工代表表决选举通过，一致同意选举王乃凤女士担任公司第四届监事 会职工代表监事（简历请详见附件），任期自公司职工代表大会审议通过之日起 至本届监事会届满之日止。 特此公告。 附件：王乃凤女士简历 江苏美思德化学股份有限公司监事会 江苏美思德化学股份有限公司 关于职工代表监事辞职及补选职工代表监事的公告 附件：职工代表监事简 ...

证券代码：603041 证券简称：美思德 公告编号：2023-048 江苏美思德化学股份有限公司 关于控股股东部分股份质押延期购回的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 佛山市顺德区德美化工集团有限公司（以下简称"德美集团"）持有江苏 美思德化学股份有限公司（以下简称"公司"）股份 74,865,000 股（无限售流通 股），占公司总股本的 40.88%。本次部分股份质押延期购回后，德美集团累计质 押公司的股份数量为 5,720,000 股，占其持有公司股份总数的 7.64%，占公司总 股本的 3.12%。 一、股东股份质押延期购回情况 1、本次股份质押延期购回基本情况 公司于 2023 年 11 月 29 日接到控股股东德美集团的通知，德美集团已将前 期质押给广发证券股份有限公司的 2,420,000 股的公司股份办理了延期购回手 续。具体情况如下： | | | 集团 | 德美 | | | | 名称 | | 股东 | | | | --- | --- | --- | --- | --- | -- ...

Financial Performance - The company's operating revenue for Q3 2023 was CNY 141,397,222.95, representing a year-on-year increase of 43.01%[3] - The net profit attributable to shareholders for Q3 2023 was CNY 29,271,177.15, an increase of 89.75% compared to the same period last year[3] - The net profit attributable to shareholders after deducting non-recurring gains and losses for Q3 2023 was CNY 26,202,749.55, up 112.89% year-on-year[4] - The basic earnings per share for Q3 2023 was CNY 0.16, a 100% increase compared to the same period last year[4] - The net profit attributable to shareholders for the year-to-date period increased by 47.64% due to the growth in main business profits[7] - The diluted earnings per share for the year-to-date period was CNY 0.44, reflecting a 33.33% increase compared to the same period last year[8] - Total operating revenue for the first three quarters of 2023 reached ¥376,469,736.01, a slight increase of 0.57% compared to ¥374,260,743.43 in the same period of 2022[19] - Net profit for the third quarter of 2023 was ¥79,839,148.72, representing a significant increase of 47.5% compared to ¥54,112,118.45 in the same quarter of 2022[20][21] - Basic and diluted earnings per share for the third quarter were both ¥0.44, up from ¥0.33 in the same period last year, indicating a 33.33% increase[21] Assets and Liabilities - The total assets at the end of Q3 2023 were CNY 1,683,954,217.56, reflecting a 6.66% increase from the end of the previous year[4] - The total assets of the company as of the end of the third quarter amounted to ¥1,683,954,217.56, an increase from ¥1,578,878,165.66 at the end of the previous year[16] - Total liabilities increased to ¥253,795,005.94, compared to ¥203,291,908.30 in the previous year, reflecting a growth of 24.87%[16] - The company's total equity reached ¥1,430,159,211.62, up from ¥1,375,586,257.36, marking an increase of 3.98%[16] Cash Flow - The net cash flow from operating activities for the year-to-date period was CNY 77,100,675.70, an increase of 39.18% compared to the same period last year[7] - The cash flow from operating activities for the first three quarters of 2023 showed positive trends, contributing to the overall financial health of the company[23] - The net cash flow from operating activities for the first three quarters of 2023 was ¥77,100,675.70, an increase of 39.2% compared to ¥55,394,458.91 in the same period of 2022[24] - Total cash inflow from operating activities reached ¥538,165,915.60, up from ¥325,605,793.36, reflecting a growth of 65.3% year-on-year[24] - Cash outflow from operating activities increased to ¥461,065,239.90 from ¥270,211,334.45, representing a rise of 70.7%[24] - The cash flow from investment activities showed a net outflow of ¥187,588,483.15, an improvement from a net outflow of ¥570,797,395.62 in the previous year[25] - Cash inflow from investment activities totaled ¥1,252,754,547.40, significantly higher than ¥401,202,316.90 in the same period last year[24] - The cash outflow for investment activities was ¥1,440,343,030.55, compared to ¥971,999,712.52, indicating a 48.1% increase[25] - The net cash flow from financing activities was negative at -¥25,360,683.46, contrasting with a positive net flow of ¥395,899,367.38 in the previous year[25] - The ending balance of cash and cash equivalents was ¥138,884,815.39, up from ¥116,875,366.80 year-on-year[25] Shareholder Information - The total number of shareholders with voting rights at the end of the reporting period was 10,123[10] - Foshan Shunde Demai Chemical Group Co., Ltd. held 74,865,000 shares, accounting for 40.88% of the total share capital[11] - Nanjing Shichuang Commodity Co., Ltd. held 7,962,030 shares, representing 4.35% of the total share capital[11] - The total current assets as of September 30, 2023, amounted to RMB 980,206,319.33, a decrease from RMB 1,045,431,158.42 at the end of 2022[14] - The company's cash and cash equivalents were RMB 276,163,745.68, down from RMB 544,642,609.54 at the end of 2022[14] - The total non-current assets were RMB 1,000,000,000.00, with significant investments in fixed assets and construction in progress[14] - The company reported a total of 1,999,953 shares held in the repurchase special securities account[11] - The top ten shareholders collectively held a significant portion of the company's shares, indicating concentrated ownership[11] Research and Development - The company attributed the increase in operating revenue primarily to the sales growth of new soft foam products[7] - The company is focused on expanding its market presence and enhancing its product offerings through ongoing research and development initiatives[12] - Research and development expenses for the third quarter were ¥23,437,719.12, an increase of 23.56% from ¥19,012,774.44 in the same quarter of 2022[20] - The company reported an investment income of ¥7,263,873.36, significantly higher than ¥1,371,022.55 from the previous year, indicating a strong performance in this area[20]

2022 年 10 月 27 日，江苏美思德化学股份有限公司（以下简称"公司"）召 开了第四届董事会第九次会议和第四届监事会第九次会议，审议通过了《关于以 集中竞价交易方式回购公司股份方案的议案》。2022 年 11 月 04 日，公司披露 了《关于以集中竞价交易方式回购公司股份方案的回购报告书》。本次回购股份 方案的主要内容如下： 公司拟使用自有资金以集中竞价交易方式回购公司部分社会公众股份，用于 实施股权激励或员工持股计划。本次拟回购的数量不低于 180 万股（含）且不超 过 360 万股（含）。以不超过 17.5 元/股（含）的价格回购公司股份，拟回购资 金总额上限为 6,300 万元（含）。本次回购股份的实施期限为自董事会审议通过 本次回购股份方案之日起 12 个月内。 证券代码：603041 证券简称：美思德 公告编号：2023-047 江苏美思德化学股份有限公司 关于回购股份实施结果暨股份变动公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、回购审批情况和回购方案内容 由于公司 2022 年年度权益分派 ...